ArticlePloS one2026
A portable, ultra-low cost, open-source, pedal-controlled microinjector for laboratory use.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In vivo transduction or electroporation often requires sub-microliter volume injection of virus or recombinant DNA/RNA to a precise anatomic site. Two-hand manual manipulation of the injection needle and target tissues is dramatically faster than mechanical manipulation, but technically challenging for operators. Here, we present an all open-source, footswitch-actuated injector for nano- or microliter volumes. Our microinjector is simple, can be assembled in less than 2 hours with ordinary tools, does not require custom fabrication or soldering, and can cost less than $130 USD. This device is completely self-contained, pressure controllable, and offers both aspirate and discharge modes to facilitate multiple injections during the same procedure. Pulse-triggered discharges can reliably deliver nanoliter volumes with dispense errors of around 15%. By reducing technical and financial barriers, we anticipate this microinjector may inspire adoption of in vivo electroporation or genome editing across broader scientific communities where access may be presently limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.